SEK115.85 -1.5 -1.2%
Last Trade - 1:26pm
| Market Cap | £3.85bn |
| Enterprise Value | £4.03bn |
| Revenue | £1.21bn |
| Position in Universe | 152nd / 1831 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 30th Apr | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 10,839 | 11,221 | 10,704 | 11,573 | 13,555 | 14,601 | 14,315 | 15,530 | +6.1% | ||
| -54.2 | +7.5 | -22.5 | +191.4 | -15.1 | -5.3 | +26.6 | +16.0 | |||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Elekta publ AB is a Sweden-based human care company that develops and sells clinical solutions for the treatment of cancer and brain disorder. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. The Company has four product areas: Elekta Neuroscience, which develops solutions for the diagnosis and treatment of neurological diseases; Elekta Oncology, which creates clinical solutions for radiation therapy, such as linear accelerators, integrated imaging systems and clinical solutions for patient positioning and immobilization; Elekta Brachytherapy, which is engaged in the treatment of cancer through internal radiation, and Elekta Software, which develops software solutions for patient information, workflow management and treatment planning in oncology. The Company owns the service business of Asesores Electronicos Especializados SA de CV (AEESA).
| Last Annual | April 30th, 2020 |
| Last Interim | January 31st, 2021 |
| Public Since | March 1, 1994 |
| No. of Shareholders: | n/a |
| No. of Employees: | 4,128 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | FTSE Euromid , |
| Exchange | OMX Nordic Exchange Stockholm |
| Shares in Issue | 382,083,120 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | Kungstensgatan 18 Box 7593, STOCKHOLM, 103 93, Sweden |
| Web | https://www.elekta.com/ |
| Phone | +46 8 58725400 |
| Contact | Cecilia Ketels (Head of Investor Relations) |
| Auditors | Ernst & Young AB |
As of 1:26pm, shares in Elekta AB (publ) are trading at SEK115.85, giving the company a market capitalisation of £3.85bn. This share price information is delayed by 15 minutes.
Shares in Elekta AB (publ) are currently trading at SEK115.85 and the price has moved by 35.11% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Elekta AB (publ) price has moved by 4.69% over the past year.
Of the analysts with advisory recommendations for Elekta AB (publ), there are there are currently 3 "buy" , 3 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Elekta AB (publ) is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Elekta AB (publ) is scheduled to issue upcoming financial results on the following dates:
The Elekta AB (publ) dividend yield is 1.53% based on the trailing twelve month period.
Last year, Elekta AB (publ) paid a total dividend of 1.8, and it currently has a trailing dividend yield of 1.53%. Looking ahead, shares in Elekta AB (publ) are due to go ex-dividend on 2021-04-19 and the next dividend pay date is 2021-04-23.
Elekta AB (publ) are due to go ex-dividend on 2021-04-19 and the next dividend pay date is 2021-04-23. The historic dividend yield on Elekta AB (publ) shares is currently 1.53%.
To buy shares in Elekta AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Elekta AB (publ) are currently trading at SEK115.85, giving the company a market capitalisation of £3.85bn.
Here are the trading details for Elekta AB (publ):
Based on an overall assessment of its quality, value and momentum, Elekta AB (publ) is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Elekta AB (publ) are currently priced at SEK115.85. At that level they are trading at 2.24% discount to the analyst consensus target price of 0.00.
Analysts covering Elekta AB (publ) currently have a consensus Earnings Per Share (EPS) forecast of 3.593 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Elekta AB (publ). Over the past six months, the relative strength of its shares against the market has been -15.02%. At the current price of SEK115.85, shares in Elekta AB (publ) are trading at 7.07% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Elekta AB (publ) PE ratio based on its reported earnings over the past 12 months is 33.93. The shares are currently trading at SEK115.85.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Elekta AB (publ)'s management team is headed by:
Here are the top five shareholders of Elekta AB (publ) based on the size of their shareholding:
